The results of this study identified a new regulatory mechanism underlying CMF transdifferentiation, whereby TRPA1 is a mediator in the molecular pathways orchestrating CMF transdifferentiation and the cardiac fibrotic response after MI injury. Here, TRPA1 is linked to myocardial infarction.